Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1981 4
1982 3
1983 3
1984 3
1985 11
1986 8
1987 6
1988 7
1989 14
1990 10
1991 7
1992 18
1993 22
1994 21
1995 21
1996 19
1997 48
1998 55
1999 70
2000 78
2001 57
2002 66
2003 103
2004 130
2005 173
2006 195
2007 227
2008 252
2009 273
2010 346
2011 394
2012 500
2013 612
2014 651
2015 814
2016 898
2017 961
2018 1132
2019 1324
2020 1618
2021 1830
2022 2138
2023 2221
2024 913

Text availability

Article attribute

Article type

Publication date

Search Results

16,299 results

Results by year

Filters applied: . Clear all
Page 1
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Wang J, Zhou C, Yao W, Wang Q, Min X, Chen G, Xu X, Li X, Xu F, Fang Y, Yang R, Yu G, Gong Y, Zhao J, Fan Y, Liu Q, Cao L, Yao Y, Liu Y, Li X, Wu J, He Z, Lu K, Jiang L, Hu C, Zhao W, Zhang B, Shi W, Zhang X, Cheng Y; CAPSTONE-1 Study Group. Wang J, et al. Among authors: he z. Lancet Oncol. 2022 Jun;23(6):739-747. doi: 10.1016/S1470-2045(22)00224-8. Epub 2022 May 13. Lancet Oncol. 2022. PMID: 35576956 Clinical Trial.
Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial.
Xu L, Su X, He Z, Zhang C, Lu J, Zhang G, Sun Y, Du X, Chi P, Wang Z, Zhong M, Wu A, Zhu A, Li F, Xu J, Kang L, Suo J, Deng H, Ye Y, Ding K, Xu T, Zhang Z, Zheng M, Xiao Y; RELARC Study Group. Xu L, et al. Among authors: he z. Lancet Oncol. 2021 Mar;22(3):391-401. doi: 10.1016/S1470-2045(20)30685-9. Epub 2021 Feb 12. Lancet Oncol. 2021. PMID: 33587893 Clinical Trial.
Light-controlled soft bio-microrobot.
Xiong J, Li X, He Z, Shi Y, Pan T, Zhu G, Lu D, Xin H. Xiong J, et al. Among authors: he z. Light Sci Appl. 2024 Feb 26;13(1):55. doi: 10.1038/s41377-024-01405-5. Light Sci Appl. 2024. PMID: 38403642 Free PMC article.
Breakthrough of solid tumor treatment: CAR-NK immunotherapy.
Wang W, Liu Y, He Z, Li L, Liu S, Jiang M, Zhao B, Deng M, Wang W, Mi X, Sun Z, Ge X. Wang W, et al. Among authors: he z. Cell Death Discov. 2024 Jan 20;10(1):40. doi: 10.1038/s41420-024-01815-9. Cell Death Discov. 2024. PMID: 38245520 Free PMC article. Review.
Temporal transcriptomic dynamics in developing macaque neocortex.
Xu L, Yuan Z, Zhou J, Zhao Y, Liu W, Lu S, He Z, Qiang B, Shu P, Chen Y, Peng X. Xu L, et al. Among authors: he z. Elife. 2024 Feb 28;12:RP90325. doi: 10.7554/eLife.90325. Elife. 2024. PMID: 38415809 Free PMC article. Review.
Brain circuits for retching-like behavior.
Huo L, Ye Z, Liu M, He Z, Huang M, Li D, Wu Q, Wang Q, Wang X, Cao P, Dong J, Shang C. Huo L, et al. Among authors: he z. Natl Sci Rev. 2023 Sep 27;11(1):nwad256. doi: 10.1093/nsr/nwad256. eCollection 2024 Jan. Natl Sci Rev. 2023. PMID: 38288368 Free PMC article.
Separator designs for aqueous zinc-ion batteries.
Li B, Zeng Y, Zhang W, Lu B, Yang Q, Zhou J, He Z. Li B, et al. Among authors: he z. Sci Bull (Beijing). 2024 Mar 15;69(5):688-703. doi: 10.1016/j.scib.2024.01.011. Epub 2024 Jan 12. Sci Bull (Beijing). 2024. PMID: 38238207 Review.
16,299 results
You have reached the last available page of results. Please see the User Guide for more information.